Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, ...

In a multicenter, phase 2 trial across 31 centers in 10 countries, apecotrep (BI 764198) reduced proteinuria by 40% over 12 ...

Data from Boehringer Ingelheim’s Phase II apecotrep study was published in The Lancet and presented at the 2025 ASN’s Kidney Week ...

Please provide your email address to receive an email when new articles are posted on . At 36 weeks, patients receiving sparsentan experienced a mean 49.8% reduction in proteinuria from baseline.

February 16, 2010 — Proteinuria may help predict outcomes in chronic kidney disease (CKD) independent of estimated glomerular filtration rate (eGFR) level, according to the results of a ...

Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...

A systematic review and meta-analysis support greater reduction of proteinuria in patients with IgA nephropathy.

Mr. A, a 30-year-old man, is turned down for life insurance because of the presence of an unspecified amount of proteinuria. His past medical history is unremarkable, and he is not taking any ...